Methotrexate Accord

Methotrexate, the active ingredient in Methotrexate Accord, is an antimetabolite presented as a sterile solution for intra‑arterial, intramuscular, and intravenous use. It is employed in the management of rheumatoid arthritis, psoriasis, and selected malignancies such as acute lymphoblastic leukemia and non‑Hodgkin lymphoma.

GNH USA supplies Methotrexate Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation to facilitate import and distribution across multiple regions.

Methotrexate is an antimetabolite used in diseases where rapid cell proliferation is a key feature.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: limits skin cell overgrowth, improving plaque severity. - Acute lymphoblastic leukemia: interferes with malignant cell replication, supporting remission. - Non‑Hodgkin lymphoma: impedes tumor growth as part of combination chemotherapy. - Gestational trophoblastic disease: induces remission by targeting proliferative trophoblastic tissue.

Methotrexate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset occurring shortly after administration. - Fatigue: persistent tiredness that may affect daily activities. - Oral mucositis: painful sores or ulceration of the mouth lining. - Cytopenias: reduced white blood cells, red blood cells, or platelets. - Elevated liver enzymes: mild to moderate increases in hepatic transaminases.

Serious or Rare Side Effects: - Severe hepatotoxicity: potential for liver fibrosis or cirrhosis with prolonged use. - Pulmonary fibrosis: interstitial lung disease presenting with cough and dyspnea. - Life‑threatening infection: due to profound bone‑marrow suppression. - Renal failure: impaired clearance leading to drug accumulation. - Anaphylactic reaction: rare hypersensitivity requiring immediate medical attention.

When using Methotrexate Accord, careful monitoring and patient education are essential.

- Monitor blood counts: perform regular complete blood count tests to detect cytopenias. - Assess liver function: schedule periodic liver enzyme evaluations. - Avoid in pregnancy: drug is contraindicated for women who are pregnant or may become pregnant. - Use effective contraception: both patients and partners should employ reliable birth control methods. - Adjust dose in renal impairment: follow prescriber guidance for patients with reduced kidney function. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Methotrexate can interact with several medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - NSAIDs: concurrent use may increase methotrexate toxicity. - Penicillins: can reduce methotrexate clearance, raising plasma levels. - Live vaccines: heightened risk of infection when combined with methotrexate.

Moderate Interactions (Monitor Closely): - Sulfonamides: additive bone‑marrow suppression potential. - Proton pump inhibitors: may affect methotrexate absorption. - Azathioprine: combined use can intensify myelosuppression.